HER2 is a membrane-bound tyrosine kinase that when amplified contributes significantly to a tumor’s ability to proliferate and survive.
Camille Walters, PharmD, RPh
Advertisement
Articles by Camille Walters, PharmD, RPh
Advertisement
Latest Updated Articles
Herceptin Hylecta for HER2-Positive Breast CancerPublished: February 24th 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expands Approval of Sotatercept-csrk for Pulmonary Arterial Hypertension
2
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
3
Clinical Data Support Use of Low-Carbon Version of Albuterol Metered Dose Inhaler for Asthma
4
Expert Insights on Key Data from IMS 2025
5
